KineMed Receives An Investigator-Initiated Study Grant To Further Explore Mechanism(s) Of Action Associated With Welchol® In Type 2 Diabetes Melli
Links shared publicly online about this topic.
- 1,587total visits
KineMed Receives An Investigator-Initiated Study Grant To Further Explore Mechanism(s) Of Action Associated With Welchol® In Type 2 Diabetes Melli
Kinemed, inc., a translational and personalized medicine development company, announced today that the company has received an investigator initiated study grant from daiichi sankyo, inc. to condu
View full resource at medicalnewstoday.com
Tags: Diabetes, Type 2 Diabetes, Personalized Medicine, Daiichi Sankyo
Most Recently Shared on November 21, 2009 at 8:00 am By:
KineMed Receives An Investigator-Initiated Study Grant To Further Explore Mechanism(s) Of Action Associated Wit.. http://bit.ly/088sbnR
Advertisement
